Gonadorelin (Systemic)

Brand Names : Factrel, Lutrepulse, Relisorm, luteinizing hormone–releasing hormone, luteinizing hormone–releasing factor dihydrochloride, luteinizing hormone–releasing factor diacetate tetrahydrate, luteinizing hormone–/follicle-stimulating hormone–releasing hormone

Category

• Diagnostic aid, hypothalamic-pituitary-gonadal axis function
• Gonadotropin-releasing hormone
• Infertility therapy agent

Description

Gonadorelin (goe-nad-oh-RELL-in) is a medicine that is the same as gonadotropin-releasing hormone (GnRH) that is naturally released from the hypothalamus gland. GnRH causes the pituitary gland to release other hormones (luteinizing hormone [LH] and follicle-stimulating hormone [FSH]). LH and FSH control development in children and fertility in adults.

Gonadorelin is used to test how well the hypothalamus and the pituitary glands are working. It is also used to cause ovulation (release of an egg from the ovary) in women who do not have regular ovulation and menstrual periods because the hypothalamus gland does not release enough GnRH.

Gonadorelin may also be used for other conditions as determined by your doctor.

Gonadorelin is available in the following dosage form:

Parenteral
• Injection (U.S. and Canada)

Brand Names

Some commonly used brand names are:

In the U.S. -

• Factrel

In Canada -

• Factrel
• Lutrepulse
• Relisorm

Other commonly used names are luteinizing hormone-releasing hormone (LHRH), luteinizing hormone-releasing factor dihydrochloride (for gonadorelin hydrochloride), luteinizing hormone-releasing factor diacetate tetrahydrate (for gonadorelin acetate), and luteinizing hormone-/follicle-stimulating hormone-releasing hormone (LH/FSH-RH).